Adagio Medical Holdings (ADGM) Capital Expenditures (2023 - 2026)

Adagio Medical Holdings has disclosed Capital Expenditures across 4 years of filings, most recently posting $6000.0 for Q2 2026.

• In Q2 2026, Capital Expenditures fell 40.0% year-over-year to $6000.0; the TTM figure through Jun 2026 stood at -$473000.0 (down 143.59% YoY), while the FY2025 annual figure was $374000.0, down 70.78% from the prior year.
• Capital Expenditures came in at $6000.0 for Q2 2026 at Adagio Medical Holdings, up from $2000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $578000.0 in Q3 2024 to a low of -$491000.0 in Q4 2025.
• Average Capital Expenditures over 4 years is $77750.0, with a median of $15000.0 recorded in 2023.
• Year-over-year, Capital Expenditures soared 106.79% in 2025 and slumped 99.4% in 2026.
• Over 4 years, Capital Expenditures stood at $20000.0 in 2023, then jumped by 2790.0% to $578000.0 in 2024, then sank by 184.95% to -$491000.0 in 2025, then surged by 101.22% to $6000.0 in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $6000.0 in Q2 2026, $2000.0 in Q1 2026, and -$491000.0 in Q4 2025.